Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-12

Clinical Trial Update: Frovatriptan and Menstrual Migraine

View source ↗

Summary

A clinical trial evaluating frovatriptan for menstrual migraine has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FROVATRIPTAN (FROVATRIPTAN SUCCINATE)

Snippet

Sponsor: Mclean Hospital | Conditions: Frovatriptan, Menstrual Migraine | Status: TERMINATED